INDICATION

Renofix is indicated for treatment of adult patients with symptomatic anemia associated with chronic kidney disease (CKD).

DOSAGE & ADMINISTRATION

The appropriate dose of Roxadustat must be taken orally three times per week and not on consecutive days. The dose should be individualized to achieve and maintain target Hb levels of 10 to 12 g/dL as described below:

Patients not on erythropoiesis-stimulating agent treatment: For adults, the usual starting dose is 50 mg three times weekly. The recommended starting dose of Roxadustat is 70 mg three times per week in patients weighing less than 100 kg and 100 mg three times per week in patients weighing 100 kg and over.

Patients switching from erythropoiesis-stimu¬ lating agents: For adults, the usual starting dose is 70 or 100 mg three times weekly. The dosage thereafter should be adjusted according to the patient's condition. 
 

FIND A PRODUCT